162 related articles for article (PubMed ID: 33014235)
1. Scalable manufacture of a disposable, storage-stable eight-channel microfluidic device for rapid testing of platelet, coagulation, and drug function under whole blood flow.
Rossi JM; Diamond SL
Biomicrofluidics; 2020 Sep; 14(5):054103. PubMed ID: 33014235
[TBL] [Abstract][Full Text] [Related]
2. Point of care whole blood microfluidics for detecting and managing thrombotic and bleeding risks.
Diamond SL; Rossi JM
Lab Chip; 2021 Sep; 21(19):3667-3674. PubMed ID: 34476426
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo recapitulation of trauma-induced coagulopathy and preliminary assessment of trauma patient platelet function under flow using microfluidic technology.
Li R; Elmongy H; Sims C; Diamond SL
J Trauma Acute Care Surg; 2016 Mar; 80(3):440-9. PubMed ID: 27082706
[TBL] [Abstract][Full Text] [Related]
4. Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro
Oberladstätter D; Schlimp CJ; Zipperle J; Osuchowski MF; Voelckel W; Grottke O; Schöchl H
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441771
[TBL] [Abstract][Full Text] [Related]
5. Rapid on-chip recalcification and drug dosing of citrated whole blood using microfluidic buffer sheath flow.
Muthard RW; Diamond SL
Biorheology; 2014; 51(2-3):227-37. PubMed ID: 24898333
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.
Pujadas-Mestres L; Lopez-Vilchez I; Arellano-Rodrigo E; Reverter JC; Lopez-Farre A; Diaz-Ricart M; Badimon JJ; Escolar G
PLoS One; 2017; 12(2):e0171486. PubMed ID: 28192448
[TBL] [Abstract][Full Text] [Related]
7. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
Muthard RW; Welsh JD; Brass LF; Diamond SL
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
[TBL] [Abstract][Full Text] [Related]
8. In microfluidico: Recreating in vivo hemodynamics using miniaturized devices.
Zhu S; Herbig BA; Li R; Colace TV; Muthard RW; Neeves KB; Diamond SL
Biorheology; 2015; 52(5-6):303-18. PubMed ID: 26600269
[TBL] [Abstract][Full Text] [Related]
9. Microfluidic system for simultaneous optical measurement of platelet aggregation at multiple shear rates in whole blood.
Li M; Ku DN; Forest CR
Lab Chip; 2012 Apr; 12(7):1355-62. PubMed ID: 22358184
[TBL] [Abstract][Full Text] [Related]
10. Straight Channel Microfluidic Chips for the Study of Platelet Adhesion under Flow.
Dupuy A; Ju LA; Passam FH
Bio Protoc; 2019 Mar; 9(6):e3195. PubMed ID: 33654994
[TBL] [Abstract][Full Text] [Related]
11. Coagulation Factor Concentrates Fail to Restore Alterations in Fibrin Formation Caused by Rivaroxaban or Dabigatran in Studies With Flowing Blood From Treated Healthy Volunteers.
Arellano-Rodrigo E; Lopez-Vilchez I; Galan AM; Molina P; Reverter JC; Carné X; Villalta J; Tassies D; Lozano M; Díaz-Ricart M; Escolar G
Transfus Med Rev; 2015 Oct; 29(4):242-9. PubMed ID: 26364029
[TBL] [Abstract][Full Text] [Related]
12. Effect of rivaroxaban and dabigatran on platelet functions: in vitro study.
Jourdi G; Bachelot-Loza C; Mazoyer E; Poirault-Chassac S; Duchemin J; Fontenay M; Gaussem P
Thromb Res; 2019 Nov; 183():159-162. PubMed ID: 31678711
[TBL] [Abstract][Full Text] [Related]
13. Tortuosity-powered microfluidic device for assessment of thrombosis and antithrombotic therapy in whole blood.
Luna DJ; R Pandian NK; Mathur T; Bui J; Gadangi P; Kostousov VV; Hui SR; Teruya J; Jain A
Sci Rep; 2020 Apr; 10(1):5742. PubMed ID: 32238835
[TBL] [Abstract][Full Text] [Related]
14. Impact of Tissue Factor Localization on Blood Clot Structure and Resistance under Venous Shear.
Govindarajan V; Zhu S; Li R; Lu Y; Diamond SL; Reifman J; Mitrophanov AY
Biophys J; 2018 Feb; 114(4):978-991. PubMed ID: 29490257
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions.
Orvim U; Roald HE; Stephens RW; Roos N; Sakariassen KS
Arterioscler Thromb; 1994 Dec; 14(12):1976-83. PubMed ID: 7981188
[TBL] [Abstract][Full Text] [Related]
16. A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time.
Six KR; Devloo R; Van Aelst B; Vandekerckhove P; Feys HB; Compernolle V
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287584
[TBL] [Abstract][Full Text] [Related]
17. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
Ebner M; Birschmann I; Peter A; Härtig F; Spencer C; Kuhn J; Rupp A; Blumenstock G; Zuern CS; Ziemann U; Poli S
J Am Heart Assoc; 2018 Oct; 7(19):e009807. PubMed ID: 30371316
[TBL] [Abstract][Full Text] [Related]
18. Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation.
Herbig BA; Diamond SL
J Thromb Haemost; 2015 Sep; 13(9):1699-708. PubMed ID: 26178390
[TBL] [Abstract][Full Text] [Related]
19. Use of microfluidics to assess the platelet-based control of coagulation.
Nagy M; Heemskerk JWM; Swieringa F
Platelets; 2017 Jul; 28(5):441-448. PubMed ID: 28358995
[TBL] [Abstract][Full Text] [Related]
20. Preclinical safety and efficacy of andexanet alfa in animal models.
Lu G; Hollenbach SJ; Baker DC; Tan S; Hutchaleelaha A; Curnutte JT; Conley PB
J Thromb Haemost; 2017 Sep; 15(9):1747-1756. PubMed ID: 28682477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
